findmyKOL

Roberto Benzo, MD

Basic profile

Mayo Clinic in Arizona

ORCIDNPI
RegionScottsdale, AZ · WestSpecialtyPulmonary DiseaseFocusRespiratory
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPaymentsNone reportedNIH funding2022–2025Why? →

Roberto Benzo is a Respiratory physician affiliated with Mayo Clinic in Arizona. OpenAlex indexes 98 publications with 2,381 citations (h-index 28); ClinicalTrials.gov lists 18 registered studies matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
98publications

Distinct works indexed by OpenAlex, matched via ORCID.

2,381citations

Total citations across indexed works.

28h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
18clinical trials

Investigator role on registered studies.

View trials
2NIH grants · 2022–2025

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

13400 E. Shea Blvd
Scottsdale, AZ 852590001

Telephone

480-301-8000

Provider last certified this registry record 10 Oct 2024.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Respiratory

    51.7%
    Corticosteroid31.3%
    Trelegy Ellipta57%Breo Ellipta13%Fluticasone Propionate13%Budesonide-Formoterol Fumarate11%Dulera6%
    Part D<11 patients
    Leukotriene Receptor Antagonist6.5%
    Montelukast Sodium100%
    Part D14 patients

    + 3 more classes in this area

  • Anti-infectives

    40.2%
    Macrolide Antimicrobial38.2%
    Azithromycin100%
    Part D39 patients
    Penicillins with extended spectrum1.9%
    Amoxicillin-Clavulanate Potass100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    8.1%
    Corticosteroid8.1%
    Prednisone100%
    Part D16 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

2 NIH research awards on record, funded 20222025 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”